Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
Abstract Polycystic ovary syndrome (PCOS) women have a hypercoagulable state; however, whether this is intrinsically due to PCOS or, alternatively, a consequence of its metabolic complications is unclear. We determined plasma coagulation pathway protein levels in PCOS (n = 146) and control (n = 97)...
Main Authors: | Abu Saleh Md Moin, Thozhukat Sathyapalan, Ilhame Diboun, Mohamed A. Elrayess, Alexandra E. Butler, Stephen L. Atkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-84586-y |
Similar Items
-
COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
by: Abu Saleh Md Moin, et al.
Published: (2020-12-01) -
Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome
by: Abu Saleh Md Moin, et al.
Published: (2021-03-01) -
Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome
by: Hassan Kahal, et al.
Published: (2011-01-01) -
The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
by: Abu Saleh Md Moin, et al.
Published: (2021-03-01) -
Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19
by: Abu Saleh Md Moin, et al.
Published: (2021-03-01)